A simple blood test measuring circulating tumor DNA (ctDNA) could help doctors predict how well treatment will work for some patients with advanced breast cancer.
Legitimacy increasingly flows to whoever processes uncertainty first. Markets have optimized for speed. Democracy has been ...
Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...
Forbes partners with Axiom to launch ForbesPredict ...
Billions of dollars are trading hands on sites like Polymarket and Kalshi, where people bet on everything from Taylor Swift’s ...
A Stanford AI model trained on nearly 600,000 hours of sleep data can assess future risk for dementia, heart disease and more using one night of sleep, researchers say.
—A retrospective analysis of patients with acetylcholine receptor antibody (AChR-Ab)-positive generalized myasthenia gravis (MG) who underwent thymectomy found that a majority of them had good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results